Fund Tracker
NEPHROCARENSE

Nephro Care India Limited

₹87.75NSE close, 28 Sep 2026 · market cap ₹145 cr (close × shares outstanding), shown for scale
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 31 AMCsShares outstanding and close: NSE, 28 Sep 2026Delivery: NSE bhavcopy, 28 Sep 2026 · 250 days collectedDeals: NSE deal files, 28 Sep 2026SLBM: NSE, 28 Sep 2026 · 31 days collectedMTF: NSE, 25 Sep 2026 · 30 days collectedFlags: NSE, 28 Sep 2026FPI: NSE shareholding filings collectedPledge: NSE shareholding filings collectedInsider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
—
Aug 2026
FPI holding, % of equity
—
Not in the filings collected
Fund houses holding
0
0 entered, 0 exited · Aug 2026 · index funds left out
Promoter pledge
—
Not in the filings collected

What changed

No tracked fund house held NEPHROCARE in Aug 2026 (31 AMCs tracked).

1 · Mutual funds

AMC portfolios, Aug 2026 · 31 AMCs tracked

2 · Other big holders

Named FPIs at 1% or more

No shareholding pattern for NEPHROCARE has been collected yet.
NSE shareholding filings collectedSource: NSE shareholding pattern filings (XBRL), quarterly Report a wrong number

Promoter pledge

No shareholding pattern for NEPHROCARE has been collected yet.
NSE shareholding filings collectedSource: NSE shareholding pattern filings (XBRL), quarterly Report a wrong number

3 · Insider trades

Insider and promoter

29 Jun 2026 to 26 Sep 2026
No insider or promoter trade in NEPHROCARE was disclosed 29 Jun 2026 to 26 Sep 2026.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL) Report a wrong number

4 · Trading

Delivery

28 Sep 2026
81.8%▲ +8.7 pp vs 20-day average

20-day average 73.1% · percentile 30 of the last year

81.8% of the shares traded on 28 Sep 2026 were delivered, against a 20-day average of 73.1%; that day sits at percentile 30 of the last year. By month over 26 months (Jul 2024 to Aug 2026), 72.4% of shares traded were delivered; lowest month 56.9% (Aug 2024), highest 98.7% (Dec 2025).

NSE bhavcopy, 28 Sep 2026 · 250 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily Report a wrong number

Bulk and block deals

90 days to 28 Sep 2026
No bulk or block deals in NEPHROCARE from 1 Jul 2026 to 28 Sep 2026.
NSE deal files, 28 Sep 2026Source: NSE bulk.csv and block.csv, daily Report a wrong number

5 · Leverage

SLBM borrowing

28 Sep 2026
NSE listed no SLBS open position for NEPHROCARE on any of the 31 days collected, 14 Aug 2026 to 28 Sep 2026. No SLBM trades in NEPHROCARE on 28 Sep 2026.
NSE, 28 Sep 2026 · 31 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily Report a wrong number

MTF book

25 Sep 2026
NSE listed no margin trading position for NEPHROCARE on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE margin trading disclosure (mrg_trading), daily Report a wrong number

6 · F&O ban and surveillance

Red flags

28 Sep 2026
No F&O

NEPHROCARE has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed NEPHROCARE under no ASM or GSM stage on 28 Sep 2026. Pledge invocations are not collected yet.

NSE, 28 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily Report a wrong number